Jan Modregger

Dr. Jan Modregger

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2005 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
HSHye-Won Shin
Hye-Won Shin
MHMitsuko Hayashi
Mitsuko Hayashi
SCSavvas Christoforidis
Savvas Christoforidis
SLSandra Lacas-Gervais
Sandra Lacas-Gervais
SHSebastian Hoepfner
Sebastian Hoepfner
MZMarino Zerial
Marino Zerial
Generation and turnover of phosphoinositides (PIs) must be coordinated in a spatial- and temporal-restricted manner. The small GTPase Rab5 interacts with two PI 3-kinases, Vps34 and PI3Kβ, suggesting that it regulates the production of 3-PIs at various stages of the early endocytic pathway. Here, we discovered that Rab5 also interacts directly with PI 5- and PI 4-phosphatases and stimulates their activity. Rab5 regulates the production of phosphatidylinositol 3-phosphate (PtdIns[3]P) through a dual mechanism, by directly phosphorylating phosphatidylinositol via Vps34 and by a hierarchical enzymatic cascade of phosphoinositide-3-kinaseβ (PI3Kβ), PI 5-, and PI 4-phosphatases. The functional importance of such an enzymatic pathway is demonstrated by the inhibition of transferrin uptake upon silencing of PI 4-phosphatase and studies in weeble mutant mice, where deficiency of PI 4-phosphatase causes an increase of PtdIns(3,4)P2 and a reduction in PtdIns(3)P. Activation of PI 3-kinase at the plasma membrane is accompanied by the recruitment of Rab5, PI 4-, and PI 5-phosphatases to the cell cortex. Our data provide the first evidence for a dual role of a Rab GTPase in regulating both generation and turnover of PIs via PI kinases and phosphatases to coordinate signaling functions with organelle homeostasis.

1 September 2007 in Developmental Cell
Verified
Journal Article
Closed access
KEKai S. Erdmann
Kai S. Erdmann
YMYuxin Mao
Yuxin Mao
HMHeather J. McCrea
Heather J. McCrea
RZRoberto Zoncu
Roberto Zoncu
SLSangyoon Lee
Sangyoon Lee
PCPietro De Camilli
Pietro De Camilli

16 April 2006 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
IPIsabel Pérez-Otaño
Isabel Pérez-Otaño
RLRafael Luján
Rafael Luján
STSteven J Tavalin
Steven J Tavalin
MPMarkus Plomann
Markus Plomann
JMJan Modregger
Jan Modregger
MEMichael D Ehlers
Michael D Ehlers

16 December 2019 in Nature Catalysis
Verified
Journal Article
Closed access
PDF file
SASandra Alonso
Sandra Alonso
GSGerard Santiago
Gerard Santiago
ICIsabel Cea-Rama
Isabel Cea-Rama
LFLaura Fernandez-Lopez
Laura Fernandez-Lopez
CCCristina Coscolín
Cristina Coscolín
MFManuel Ferrer
Manuel Ferrer

2 October 2002 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JMJan Modregger
Jan Modregger
NDNicholas A. DiProspero
Nicholas A. DiProspero
VCVinod Charles
Vinod Charles
DTDanilo A. Tagle
Danilo A. Tagle
MPMarkus Plomann
Markus Plomann
Huntington's disease (HD) is caused by a pathological expansion of a CAG repeat in the first exon of the gene coding for huntingtin, resulting in an abnormally long polyglutamine stretch. Despite its widespread expression, mutant huntingtin leads to selective neuronal loss in the striatum and cortex. Here we report that the neurospecific phosphoprotein PACSIN 1, which has been implicated as playing a central role in synaptic vesicle recycling, interacts with huntingtin via its C-terminal SH3 domain. Moreover, two other isoforms, PACSIN 2 and 3, which show a wider tissue distribution including the brain, do not interact with huntingtin despite a highly conserved SH3 domain. Furthermore, this interaction is repeat-length-dependent and is enhanced with mutant huntingtin, possibly causing the sequestration of PACSIN 1. Normally, PACSIN 1 is located along neurites and within synaptic boutons, but in HD patient neurons, there is a progressive loss of PACSIN 1 immunostaining in synaptic varicosities, beginning in presymptomatic and early-stage HD. Further, PACSIN 1 immunostaining of HD patient tissue reveals a more cytoplasmic distribution of the protein, with particular concentration in the perinuclear region coincident with mutant huntingtin. Thus, the specific interaction of huntingtin with the neuronal PACSIN isoform, PACSIN 1, and its altered intracellular distribution in pathological tissue, together with the observed differences in the binding behavior, suggest a role for PACSIN 1 during early stages of the selective neuropathology of HD.

9 July 1999 in FEBS Letters
Verified
Journal Article
Closed access
BRB Ritter
B Ritter
JMJan Modregger
Jan Modregger
MPM Paulsson
M Paulsson
MPM Plomann
M Plomann